Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $86.95 | $21.09 | 312.35% | 189.02x | 166.06x | 11.81x | 14.63x | 1.59x | $119.79M | 1.32% | $637.99M | 6.11 | $9.24B | -1,345.05 | ||
| LQDA | LIQUIDIA CORP | $79.73 | $17.95 | 344.26% | 332.21x | 23.34x | 24.36x | 65.30x | 1.63x | $41.15M | 0.59% | $108.58M | 1.23 | $7.05B | 131.58 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $301.03 | $95.04 | 216.73% | 69.04x | 39.91x | 9.33x | 37.37x | 1.43x | $641.34M | 1.60% | $1.08B | 8.09 | $41.45B | 44.84 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $7.92 | $2.97 | 166.45% | 113.14x | 73.95x | 4.29x | 105.09x | 1.04x | $47.52M | 3.52% | $13.01M | 0.08 | $1.51B | 28.34 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.95 | $17.60 | 263.27% | 65.26x | 50.09x | 6.49x | 8.12x | 1.77x | $164.23M | 3.36% | $605.69M | 7.92 | $4.74B | 42.51 | ||
| KRYS | KRYSTAL BIOTECH INC | $371.67 | $96.94 | 283.40% | 47.96x | 46.75x | 26.09x | 8.58x | 2.29x | $237.38M | 2.18% | $1.28B | 43.59 | $10.46B | 48.91 | ||
| ADMA | ADMA BIOLOGICS INC | $8.37 | $9.99 | -16.23% | 12.13x | 9.15x | 3.88x | 4.97x | 0.45x | $107.90M | 5.46% | $390.33M | 1.65 | $2.00B | 9.03 | ||
| HALO | HALOZYME THERAPEUTICS INC | $78.27 | $72.50 | 7.95% | 26.44x | 9.44x | 6.13x | 42.27x | 0.47x | $667.65M | 7.22% | $219.64M | 1.86 | $11.12B | 17.82 | ||
| RPRX | ROYALTY PHARMA PLC | $56.07 | $40.53 | 38.33% | 29.36x | 10.51x | 10.04x | 3.25x | 0.63x | $2.34B | 9.56% | $9.94B | 22.75 | $40.66B | 34.95 | ||
| VCEL | VERICEL CORP | $44.49 | $9.29 | 379.14% | 103.47x | 92.28x | 7.73x | 6.38x | 2.18x | $47.49M | 2.10% | $356.23M | 7.02 | $2.26B | 55.85 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.22 | $42.46 | 34.76% | 40.87x | 15.09x | 3.40x | 1.78x | 0.56x | $767.06M | 6.96% | $6.21B | 32.27 | $9.42B | 19.52 | ||
| ASND | ASCENDIS PHARMA A | $266.72 | $82.01 | 225.23% | 28.27x | 17.88x | 16.26x | 28.86x | 2.89x | $52.94M | 0.32% | $574.09M | 9.24 | $16.95B | 181.73 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $14.34 | $16.23 | -11.63% | 7.00x | 29.91x | 6.85x | 4.12x | 0.93x | $56.42M | 6.74% | $205.80M | 3.52 | $753.26M | 5.21 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.97 | $50.21 | 379.95% | 512.70x | 9.36x | 3.36x | 3.34x | 1.73x | $1.30B | 8.70% | $4.53B | 73.22 | $18.68B | 27.67 | ||
| TGTX | TG THERAPEUTICS INC | $54.94 | $17.31 | 217.34% | 17.06x | 39.28x | 11.33x | 14.42x | 270.37x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.72B | 58.12 | ||
| TECH | BIO-TECHNE CORP | $70.65 | $17.06 | 314.18% | 99.51x | 33.82x | 9.12x | 5.30x | 1.82x | $269.60M | 2.44% | $2.09B | 13.34 | $11.14B | 43.53 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.21 | $5.83 | -62.08% | 8.19x | 3.23x | 2.07x | 2.42x | 0.17x | $7.24M | 5.70% | $52.93M | 0.92 | $74.31M | 4.80 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $316.09 | $95.92 | 229.52% | 40.01x | 34.83x | 22.90x | 6.35x | 2.01x | $122.22M | 1.94% | $997.32M | 50.16 | $6.67B | 29.58 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.41 | $36.33 | 0.22% | 14.39x | 9.90x | 2.34x | 2.32x | 0.55x | $341.79M | 16.23% | $910.35M | 15.75 | $1.68B | 7.08 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.43 | $12.45 | 152.52% | 17.36x | 16.03x | 6.44x | 3.80x | 3.90x | $208.13M | 5.42% | $1.01B | 8.28 | $3.09B | 9.23 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $496.73 | $170.66 | 191.06% | 29.20x | 25.41x | 10.33x | 6.51x | 2.13x | $3.71B | 2.94% | $19.36B | 76.20 | $122.57B | 22.73 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.19 | $2.50 | 27.62% | 13.29x | 13.48x | 1.95x | 3.09x | 0.90x | $4.11M | 1.60% | $82.33M | 1.03 | $190.09M | 8.95 | ||
| EXEL | EXELIXIS INC | $54.41 | $31.35 | 73.57% | 17.44x | 16.52x | 5.92x | 7.07x | 1.27x | $917.69M | 6.53% | $1.94B | 7.49 | $13.62B | 12.90 | ||
| UTHR | UNITED THERAPEUTICS CORP | $541.83 | $247.20 | 119.19% | 18.51x | 19.04x | 7.44x | 3.90x | 2.05x | $1.02B | 4.31% | $5.90B | 135.66 | $21.72B | 12.68 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $623.54 | $443.08 | 40.73% | 14.65x | 13.25x | 4.35x | 2.08x | 0.99x | $4.11B | 6.34% | $31.42B | 302.15 | $65.11B | 11.33 | ||
| INCY | INCYTE CORP | $113.36 | $67.95 | 66.83% | 15.55x | 14.47x | 4.22x | 4.03x | 1.34x | $1.45B | 6.42% | $5.62B | 28.21 | $19.22B | 10.27 | ||
| VCYT | VERACYTE INC | $58.73 | $7.72 | 660.37% | 52.91x | 52.66x | 8.62x | 3.49x | 11.27x | $155.34M | 3.33% | $1.34B | 16.90 | $4.46B | 38.77 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.97 | $3.67 | 390.21% | 29.95x | 4.90x | 0.86x | 1.26x | 13.55x | $109.24M | 5.79% | $1.51B | 14.34 | $2.47B | 29.85 | ||
| MDXG | MIMEDX GROUP INC | $3.85 | $1.28 | 201.88% | 18.33x | -45.72x | 1.47x | 2.36x | 8.72x | $69.36M | 12.13% | $242.94M | 1.64 | $431.26M | 7.92 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.